Harry A. Gampel Pavilion is a 10,167-seat multi-purpose arena in Storrs, Connecticut, United States, on the campus of the University of Connecticut. The arena opened on January 21, 1990, and is the largest on-campus arena in New England.

During the past decade, Gampel Pavilion conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gampel Pavilion" #1 collaborator was "Biotechnology High Performance Computing Software Applications Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Gampel Pavilion" are "Hyperthermia" (2 trials). Many other conditions were trialed in "Gampel Pavilion" in a lesser frequency.

Most popular intervention types in "Gampel Pavilion" are "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Forearm cooling" (2 trials) and "Mist-fan cooling" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gampel Pavilion" are 2 trials for "Male" genders.

Currently, there are NaN active trials in "Gampel Pavilion". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Gampel Pavilion, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gampel Pavilion, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".